Assignee
LAVA THERAPEUTICS N V
NL·5 granted patents·11 pending applications·5 citations·filing 2019–2024
Top patents by PatentIndex Score
16 records- 0193US11384145B2Immunoglobulins binding human Vγ9Vδ2 T cell receptorsLAVA THERAPEUTICS N V·Filed 2021·Granted Jul 12, 2022·3 cites·21 claims
- 0283US11591394B2Single domain antibodies targeting CD1dLAVA THERAPEUTICS N V·Filed 2019·Granted Feb 28, 2023·2 cites·8 claims
- 0381US2024425592A1Single domain antibodies targeting cd1dLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 0478US12110328B2Single domain antibodies targeting CD1dLAVA THERAPEUTICS N V·Filed 2023·Granted Oct 8, 2024·0 cites·15 claims
- 0576US2023212290A1Immunoglobulins binding human vgamma9vdelta2 t cell receptorsLAVA THERAPEUTICS N V·Filed 2022·Application pending·0 cites
- 0673US12428493B2Antibodies that bind PSMA and gamma-delta T cell receptorsLAVA THERAPEUTICS N V·Filed 2024·Granted Sep 30, 2025·0 cites·8 claims
- 0766US2025099581A1Uses of gamma delta t cell activating antibodiesLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 0865US2025270660A1Assay for t cell dependent multispecific compoundsLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 0961US2024409641A1Dual acting cd1d immunoglobulin for treatment of myelodysplastic syndromesLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 1060US2025109204A1Compositions comprising antibodies that bind gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 1160US2025230240A1Variant antibodies that bind gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2024·Application pending·0 cites
- 1255US2023303694A1Antibodies that bind gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2023·Application pending·0 cites
- 1353US2024141071A1Antibodies that bind cd123 and gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2022·Application pending·0 cites
- 1453US2023272110A1Antibodies that bind psma and gamma-delta t cell receptorsLAVA THERAPEUTICS N V·Filed 2021·Application pending·0 cites
- 1550US12077586B2Bispecific antibodies for use in the treatment of hematological malignanciesLAVA THERAPEUTICS N V·Filed 2019·Granted Sep 3, 2024·0 cites·13 claims
- 1650US2023036284A1TREATMENT OF CANCER COMPRISING ADMINISTRATION OF Vg9Vd2 T CELL RECEPTOR BINDING ANTIBODIESLAVA THERAPEUTICS N V·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LAVA THERAPEUTICS N V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →